Edition:
United States

Insider Trading: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,643.50GBp
26 May 2017
Change (% chg)

25.50 (+1.58%)
Prev Close
1,618.00
Open
1,626.50
Day's High
1,649.50
Day's Low
1,626.50
Volume
9,262,367
Avg. Vol
9,303,001
52-wk High
1,745.56
52-wk Low
1,363.00

All Insider Trades

Institutional Holders

% Shares Owned: 52.33%
# of Holders: 727
Total Shares Held: 2,573,199,227
3 Mo. Net Change: 73,168,586
# New Positions: 9
# Closed Positions: 22
# Increased Positions: 146
# Reduced Positions: 124
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

Philip Hampton

63 2015 Non-Executive Chairman of the Board

Emma Walmsley

46 2017 Chief Executive Officer - Designate, Executive Director

Simon Dingemans

52 2011 Chief Financial Officer, Executive Director

Patrick Vallance

2017 President - Pharmaceuticals R&D, Executive Director

Roger Connor

2013 President - Global Manufacturing & Supply

Abbas Hussain

2014 President - Global Pharmaceuticals

Shah Abbas Hussain

2015 President - Global Pharmaceuticals

Luke Miels

2017 President - Global Pharmaceuticals

Daniel Troy

2008 Senior Vice President, General Counsel

Claire Thomas

2008 Senior Vice President - Human Resources

Nick Hirons

2014 Senior Vice President – Global Ethics and Compliance

Phil Thomson

2014 Senior Vice President - Communications and Government Affairs

David Redfern

50 2008 Chief Strategy Officer

Victoria Whyte

2011 Company Secretary

Roy Anderson

68 2007 Non-Executive Independent Director

Manvinder Banga

61 2015 Non-Executive Independent Director

Vindi Banga

2017 Senior Independent Non-Executive Director

Vivienne Cox

57 2017 Non-Executive Independent Director

Lynn Elsenhans

60 2012 Non-Executive Independent Director

Jesse Goodman

64 2017 Non-Executive Independent Director

Judy Lewent

68 2011 Non-Executive Independent Director

Urs Rohner

58 2015 Non-Executive Independent Director